Lymphocytic bronchiolitis is associated with inadequate suppression of blood T-cell granzyme B, IFN-gamma, and TNF-alpha

Transplantation. 2010 May 27;89(10):1283-9. doi: 10.1097/TP.0b013e3181d75971.

Abstract

Background: Lymphocytic bronchiolitis (LB) has been shown to be an important factor for the subsequent development of obliterative bronchiolitis (OB). We have previously shown that OB, which limits long-term survival after lung transplantation, is associated with lack of suppression of peripheral blood T-cell granzyme B, interferon (IFN)-gamma, and tumor necrosis factor (TNF)-alpha. However, the role of these proinflammatory mediators in LB is unknown. We hypothesized that these proinflammatory mediators may also be increased during LB episodes despite standard immunosuppression regimens.

Methods: T-cell intracellular cytokine profiles and granzyme B were studied in whole blood, bronchoalveolar lavage samples, and bronchial brushings from stable lung transplant patients with LB and from healthy controls, using multiparameter flow cytometry.

Results: There was a significant increase in peripheral blood T-cell granzyme B and CD8 T-cell IFN-gamma and TNF-alpha in patients with LB compared with control and stable groups and a decrease in CD25CD127CD3CD8 T regulatory cells in stable and LB transplant patients compared with controls. No changes were noted in the airways.

Conclusions: LB is associated with inadequate suppression of peripheral blood T-cell granzyme B, IFN-gamma, and TNF-alpha. Drugs that effectively reduce these proinflammatory mediators may improve current protocols for treating LB and possibly reduce subsequent progression to OB in lung transplant patients.

MeSH terms

  • Bronchiolitis / etiology*
  • Bronchiolitis / immunology
  • Bronchoalveolar Lavage
  • CD4-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / immunology
  • Cyclosporine / blood
  • Cyclosporine / therapeutic use
  • Cytokines / blood
  • Granzymes / antagonists & inhibitors*
  • Granzymes / blood
  • Humans
  • Immunosuppression Therapy
  • Immunosuppressive Agents / blood
  • Immunosuppressive Agents / therapeutic use
  • Leukocyte Count
  • Lung Transplantation / immunology*
  • Lung Transplantation / mortality
  • Postoperative Complications / epidemiology*
  • Postoperative Complications / immunology*
  • Survival Analysis
  • T-Lymphocytes / enzymology
  • T-Lymphocytes / immunology*
  • T-Lymphocytes, Regulatory / immunology
  • Tacrolimus / blood
  • Tacrolimus / therapeutic use
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*

Substances

  • Cytokines
  • Immunosuppressive Agents
  • Tumor Necrosis Factor-alpha
  • Cyclosporine
  • Granzymes
  • Tacrolimus